Cold Pain Therapy Market Analysis 2024 -2033: Forecasted Market Size, Top Segments, And Largest Region | Unexo Lifesciences Pvt. Ltd., Össur Corporate, Hisamitsu Pharmaceutical Co. Inc., Johnson & Johnson

The Business Research Company has updated its global market reports, featuring the latest data for 2024 and projections up to 2194

The Business Research Company offers in-depth market insights through Cold Pain Therapy Global Market Report 2024, providing businesses with a competitive advantage by thoroughly analyzing the market structure, including estimates for numerous segments and sub-segments.

Market Size And Growth Forecast:
The cold pain therapy market size has grown strongly in recent years. It will grow from $1.66 billion in 2023 to $1.79 billion in 2024 at a compound annual growth rate (CAGR) of 7.4%. The growth in the historic period can be attributed to rise in sports injuries, chronic pain management, post-surgery recovery, orthopedic applications, fitness and rehabilitation..

The cold pain therapy market size is expected to see strong growth in the next few years. It will grow to $2.36 billion in 2028 at a compound annual growth rate (CAGR) of 7.2%. The growth in the forecast period can be attributed to professional endorsements, innovative marketing strategies, digital health adoption, supportive regulatory environment, geriatric population demand, rise in orthopedic conditions.. Major trends in the forecast period include increased sports and fitness focus, shift towards non-pharmacological methods, at-home treatment preference..

Get Free Sample Of This Report-
https://www.thebusinessresearchcompany.com/sample.aspx?id=8358&type=smp

Market Segmentation:
The cold pain therapy market covered in this report is segmented -

1) By Product: OTC Products, Prescription Products
2) By Distribution Channel: Retail Pharmacies, Hospital Pharmacies, E- Pharmacies
3) By Application: Musculoskeletal Disorders, Post-operative Therapy, Sports Injuries, Post-trauma Therapy

Major Driver - The Symbiotic Rise Gym Activities Fueling The Surge In Cold Pain Therapy Market
The increased importance of gym activities is significantly contributing to the growth of the cold pain therapy market. Gym activities are increasing due to the need to improve brain health, help manage weight, lower the risk of disease, strengthen bones and muscles, and improve the ability to do everyday tasks. Cold pain therapy products alleviate pain caused by musculoskeletal injuries that occur in gym activities. For instance, in March 2022, according to a report by the Australia Bureau of Statistics, an agency of the Australian Government responsible for statistical collection and analysis, 73.4% of adults aged between 18 and 64 in Australia undertook 150 minutes or more of physical activity regularly, thereby increasing the potential for muscle and tendon injuries. Therefore, the increasing importance of gym activities will drive the cold pain therapy market.

Competitive Landscape:
Major companies operating in the cold pain therapy market report are Unexo Lifesciences Pvt. Ltd., Össur Corporate, Hisamitsu Pharmaceutical Co. Inc., Johnson & Johnson, Pfizer Inc., Sanofi S.A., Rohto Pharmaceutical Co. Ltd., 3M Company, Cardinal Health Inc., Compass Health Brands, Breg Inc., Medline Industries LP, Performance Health Supply Inc., Romsons Group of Industries, Beiersdorf AG, DJO Global Inc., Gilead Sciences Inc., Astellas Pharma Inc., AstraZeneca plc, Novo Nordisk A/S, Polar Products Inc., The Bristol-Myers Squibb Company, Mueller Sports Medicine Inc., Eli Lilly and Company, Bruder Healthcare Company LLC, ThermoTek Inc., Boehringer Ingelheim International GmbH, GlaxoSmithKline plc, Medtronic plc, Performance Health LLC

Get Access To The Full Market Report -
https://www.thebusinessresearchcompany.com/report/cold-pain-therapy-global-market-report

Top Trend - Technological Advancements Paving The Way In The Cold Pain Therapy Market
Technological advancement is the key trend gaining popularity in the cold pain therapy market. Major companies operating in the cold pain therapy market are trying to come up with new technological advancements in their product offerings to gain a competitive edge in the market. For instance, in April 2022, Jenburkt Wellness, an India-based company operating in cold pain therapy unveiled Zixa Strong, an innovative fast-acting pain relief range. This involves innovative oil-in-water flash micelle technology, a combination of ultra-rapid mixing techniques, and a uniquely powerful approach to modify the structure with oil-based formulations that improve therapeutic efficacy.

The Table Of Content For The Market Report Include:
1. Executive Summary
2. Cold Pain Therapy Market Characteristics
3. Cold Pain Therapy Market Trends And Strategies
4. Cold Pain Therapy Market - Macro Economic Scenario
5. Cold Pain Therapy Market Size And Growth
…..
27. Cold Pain Therapy Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx

About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialize in various industries including manufacturing, healthcare, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries.

This release was published on openPR.